Reason for request
Inclusion on the list of medicines refundable by National Health Insurance and approved for hospital use.
Clinical Benefit
| Low |
The actual benefit of BRONCHITOL is low. |
Clinical Added Value
| no clinical added value |
BRONCHITOL does not offer any improvement in actual benefit (IAB V) in the management of adult patients aged 18 and over with cystic fibrosis. |
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
PrMKBXuB4eUpwV29
